About the new and improved Hot Tort Report
Being industry experts, we pride ourselves on keeping our finger on the pulse of all things Multi District Litigation. This predominantly consists of providing our subscribers with competitive insights into where the money is being spent in hopes of informing your blueprint for advertising strategies. These cases can be highly lucrative, but are difficult to acquire, requiring significant investment and patience to secure high-value cases.
We’ve been working hard on an algorithm to deliver more than just monthly TV spends and are proud to announce that we are ready to unveil our HTR 2.0.
This new list offers an overview of dollars spent across TV, Meta, PPC, and more, assigning a score to each tort based on what we, as leaders in the law firm advertising space, are witnessing across these various platforms.
The Hot Tort Report:
August 2025
The Hottest in Mass Tort Spending: July 2025
Birth Control Injections
Featured Tort
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: August, 2025. Advertising spend from multiple sources for a recent 30 day period.
If you have any questions, please contact us at national@whitehardt.com
#1 AFFF
The AFFF mass tort has taken the top spot this month with sharp gains across all fronts. After no TV ad spending in June, July brought a 1.2-point jump as firms returned to the airwaves. Meta rose 1.6 points for a maxed-out total score, and Whitehardt’s WHii Index spiked 1.9 points, reflecting renewed digital heat. The tort continues to expand as new personal injury claims join the MDL and state-level PFAS legislation accelerates nationwide. With corporate defendants under mounting pressure and advertising fully reignited, this mass tort is firmly back in the spotlight.
CPA: $3,500
CPL: $1,750
For common criteria, please contact us.
#2 Birth Control Injections
The Birth Control Injections mass tort holds steady at #2, gaining traction across advertising and legal fronts. While Meta performance dropped 1.6 points, PPC climbed by 1, signaling a shift in strategy from social to paid search. TV remains strong with a score of 5.0, anchoring the campaign’s visibility.
As of a July 14th case management order, the MDL now includes at least 550 product liability cases against Pfizer and other manufacturers. Now is the time to get involved in this important legislation affecting women across the country.
CPA: $1,364 – $4,890
CPL: $682 – $2,445
For common criteria, please contact us.
#3 Ultra-Processed Foods
The Ultra-Processed Foods mass tort climbs back to #3 after falling to 7th last month, driven largely by a rise in WHii. While Meta dropped slightly and PPC held steady, increased behind-the-scenes interest and legal chatter helped push this tort back up the leaderboard.
There’s still no TV presence, but regulatory momentum is building: on July 23, the FDA, USDA, and HHS jointly announced a plan to create the first-ever federal definition of “ultra-processed foods.” With 70% of packaged foods potentially falling under that label and mounting concern over links to chronic illness, this tort could be poised for broader action.
For metrics such as CPA, CPL, and common criteria, please contact us.
#5 Takata Airbag Recall
The Takata Airbag Recall mass tort rises to #5 this month with a boost in both TV ad spending and WHii. TV climbed to a strong 5.0, helping to drive broader awareness, while WHii saw a modest gain, reflecting increased engagement behind the scenes. Meta and PPC held steady, with digital efforts still limited. While the tort remains relatively quiet online, the renewed broadcast push signals a potential resurgence in attention to one of the longest-running automotive defect litigations.
For metrics such as CPA, CPL, and common criteria, please contact us.
#6 Paraquat
The Paraquat mass tort drops from #3 to #6 this month following declines in both Meta performance and WHii. While PPC and TV held steady, digital momentum slowed, with Meta down and WHii slipping alongside it. Despite no major changes in paid strategy, this dip in engagement caused the tort to slide in the rankings. With ad support still focused on Meta and PPC, it remains to be seen whether Paraquat will regain its previous position or continue to cool. If you’re looking to get involved in this tort, we can help you make the necessary connections.
CPA: $711
CPL: $320
Common Criteria: Diagnosis of Parkinson’s Disease or experiencing Parkinson’s-like symptoms after exposure to Paraquat.
#7 Diabetes Meds for Weight Loss
The Diabetes Meds for Weight Loss mass tort holds at #7, with rising WHii and TV scores offsetting digital pullback. WHii climbed to 4.9 and TV spending ticked up slightly, signaling ongoing interest, particularly as public scrutiny of GLP-1 drugs like Ozempic and Wegovy continues.
However, Meta and PPC dropped to zero, indicating a pause in digital campaigns. With media attention and legal speculation still simmering, now is the time for firms to reenter the space. Whitehardt can help you capitalize on this window with tailored creative and media strategies built to move fast.
CPA: $148 – $224
CPL: $74 – $112
Common Criteria: Took a prescription diabetes drug for weight loss (e.g. Ozempic, Mounjaro), discontinued use of the drug, and experienced one or more gastrointestinal disorders at least 30 days after your first dose.
#8 Clergy Abuse
The Clergy Abuse mass tort slides into the top ten at #8 as TV spend pulls back, but Meta climbs to its highest level yet. With a score of 5.0, Meta now leads the campaign’s performance, while TV dropped to just 1.0 and WHii and PPC remain flat at zero. The shift suggests a tighter, digitally focused strategy as firms lean into direct targeting over broader broadcast.
For metrics such as CPA, CPL, and common criteria, please contact us.
#9 Roundup®
The Roundup® mass tort continues its gradual descent, now sitting at #9 as activity declines across all platforms. Meta and PPC both slipped, WHii dropped to 0.8, and there’s still no TV spend in play. Though this litigation has long been a staple in the mass tort landscape, recent slowdown suggests firms may be shifting budgets elsewhere. Unless momentum returns soon, Roundup® could continue sliding out of the top 10.
CPA: $1,238
CPL: $743
For common criteria, please contact us.
Mesothelioma
You may be noticing a tort missing from our new report. While Mesothelioma continues to dominate the competition when it comes to spend levels, Whitehardt finds that this tort is its own niche animal. These cases can be extremely fruitful, but hard to come by, requiring a high buy-in to get in the game and patience when landing that ringer of a case. We believe that Meso will remain a constant for some time, but in regards to many of the other drugs and devices we focus on in this monthly report, we’ve decided to move it to its own category. If you are interested in hearing the latest news on Meso or how Whitehardt may be currently seeking these cases, you can contact us here.
Whitehardt will continue to track meso spending from month to month, so if you are interested in ongoing meso spending, please reach out to us directly. Going forward, we will be excluding meso from these tort reports.
#10 Social Media
The Social Media mass tort rounds out the top 10, with Meta spend falling off while WHii surged to a new high of 5.0. That shift reflects rising legal interest even as firms pause ad campaigns. On July 28, a U.S. District Judge selected six school districts as bellwether plaintiffs in the federal lawsuit alleging platforms like Instagram, TikTok, YouTube, and Snapchat have fueled a youth mental health crisis. The case accuses tech companies of intentionally designing addictive features that exploit young users, with schools overwhelmed by the resulting demand for mental health services.
For metrics such as CPA, CPL, and common criteria, please contact us.